2018-11-15 12:35:00 Thu ET
stock market gold oil stock return s&p 500 asset market stabilization asset price fluctuations stocks bonds currencies commodities funds term spreads credit spreads fair value spreads asset investments
Warren Buffett approves Berkshire Hathaway to implement new meaningful stock repurchases. Buffett sends a positive signal to the stock market with the Berkshire $1 billion stock buyback. This stock buyback program involves $1 billion Berkshire Hathaway share repurchases as of 2018Q3 and thus boosts the share price almost 5% in early-November 2018. This program can continue into the final weeks of the current calendar year.
From July 2018 to November 2018, Berkshire has been an active net buyer of $24 billion U.S. stocks. This decision doubles the overall dollar volume in the first half of the current year. Until July 2018, Berkshire Hathaway would repurchase shares only if the stock price fell below 120% of its book value (about $152 per share as of October 2018). A recent amendment allows Warren Buffett and Charlie Munger to approve share repurchases if they believe that the stock price is lower than its intrinsic value. This amendment provides greater flexibility for new stock buyback programs and so results in meaningful share repurchases at Berkshire Hathaway. Warren Buffett points out that the intrinsic value of Berkshire Hathaway far exceeds its book value particularly in the property and casualty insurance businesses.
If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.
2020-08-12 07:25:00 Wednesday ET
Most sustainably successful business leaders make a mark in the world, create a positive impact, and challenge the status quo. Jerry Porras, Stewart Emer
2022-05-05 09:34:00 Thursday ET
Corporate payout management This corporate payout literature review rests on the recent survey article by Farre-Mensa, Michaely, and Schmalz (2014). Out
2025-06-28 10:39:00 Saturday ET
Former New York Times science author and Harvard psychologist Daniel Goleman explains why great mental focus serves as a vital mainstream driver of personal
2019-04-01 08:28:00 Monday ET
OraSure and its subsidiary DNA Genotek specialize in the lean production of home DNA spit tubes. OraSure extracts core genetic information from microbiome s
2018-10-11 08:44:00 Thursday ET
Treasury bond yield curve inversion often signals the next economic recession in America. In fact, U.S. bond yield curve inversion correctly predicts the da
2019-01-10 17:31:00 Thursday ET
The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be